|Articles|March 11, 2021
Parvulet TM Technology- A Patient Centric Dosing Solution
Author(s)Adare Pharma Solutions
The Parvulet TM Technology enables the conversion of powders or tablets to a soft food like texture, ideal for pediatric and geriatric patients.
Adare Pharma Solutions is a global technology driven CDMO providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical, animal health, and OTC markets. Adare’s specialized technology platforms provide taste masking, ODTs, and customized drug release solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 40 products sold by customers in more than 100 countries globally.
Adare Pharma Solutions
Related Content
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
PharmTech Weekly Roundup–July 10, 2026
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5